Wordt geladen...
Hemodynamic and clinical effects of selexipag in children with pulmonary hypertension
Selexipag is an oral prostacyclin receptor agonist; it was recently approved for use in adults with pulmonary arterial hypertension. The safety and efficacy of selexipag has not yet been determined in the pediatric population. We describe short-term hemodynamic and clinical data with selexipag thera...
Bewaard in:
| Gepubliceerd in: | Pulm Circ |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7026823/ https://ncbi.nlm.nih.gov/pubmed/32110381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019876545 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|